We are live on ! Find out more
NSIM

North Star Investment Management Portfolio holdings

AUM $1.84B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+9.65%
1 Year Est. Return
+28.81%
3 Year Est. Return
+80.65%
5 Year Est. Return
+82.11%
10 Year Est. Return
+375.21%
AUM
$1.06B
AUM Growth
+$99.2M
Cap. Flow
+$24.5M
Cap. Flow %
2.31%
Top 10 Hldgs %
22.16%
Holding
1,110
New
65
Increased
211
Reduced
153
Closed
37

Sector Composition

Rank Sector Weight
1 Industrials 13.94%
2 Financials 12.98%
3 Consumer Discretionary 12.38%
4 Technology 10.23%
5 Healthcare 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BH.A icon
1001
Biglari Holdings Class A
BH.A
$1.23B
$1K ﹤0.01%
2
BIPC icon
1002
Brookfield Infrastructure
BIPC
$4.93B
$1K ﹤0.01%
17
BKT icon
1003
BlackRock Income Trust
BKT
$341M
$1K ﹤0.01%
67
BNTX icon
1004
BioNTech
BNTX
$23.3B
$1K ﹤0.01%
12
DDD icon
1005
3D Systems Corp
DDD
$603M
$1K ﹤0.01%
20
EMD
1006
Western Asset Emerging Markets Debt Fund
EMD
$609M
$1K ﹤0.01%
73
EOSE icon
1007
Eos Energy Enterprises
EOSE
$1.54B
$1K ﹤0.01%
60
EXEL icon
1008
Exelixis
EXEL
$12.5B
$1K ﹤0.01%
60
FAS icon
1009
Direxion Daily Financial Bull 3x ETF
FAS
$2.46B
$1K ﹤0.01%
12
FSLY icon
1010
Fastly Inc
FSLY
$4.54B
$1K ﹤0.01%
17
FSP
1011
Franklin Street Properties
FSP
$46.6M
$1K ﹤0.01%
230
GDOT icon
1012
Green Dot
GDOT
$766M
$1K ﹤0.01%
+22
New +$1.15K
HYLN icon
1013
Hyliion Holdings
HYLN
$695M
$1K ﹤0.01%
+60
New +$939
IHE icon
1014
iShares US Pharmaceuticals ETF
IHE
$1.65B
$1K ﹤0.01%
21
INO icon
1015
Inovio Pharmaceuticals
INO
$78.7M
$1K ﹤0.01%
8
LKQ icon
1016
LKQ Corp
LKQ
$6.25B
$1K ﹤0.01%
28
MBRX icon
1017
Moleculin Biotech
MBRX
$3.65M
$1K ﹤0.01%
+1
New +$1.83K
MVST icon
1018
Microvast
MVST
$354M
$1K ﹤0.01%
46
+45
+4,500% +$734
NBIX icon
1019
Neurocrine Biosciences
NBIX
$15.9B
$1K ﹤0.01%
13
ON icon
1020
ON Semiconductor
ON
$32.4B
$1K ﹤0.01%
+13
New +$499
PCG icon
1021
PG&E
PCG
$38.3B
$1K ﹤0.01%
100
PPBT
1022
Purple Biotech
PPBT
$2.46M
$1K ﹤0.01%
2
RITM icon
1023
Rithm Capital
RITM
$5.71B
$1K ﹤0.01%
100
SAGE
1024
DELISTED
Sage Therapeutics
SAGE
$1K ﹤0.01%
14
SPCK
1025
The SPAC and New Issue ETF
SPCK
$8.2M
$1K ﹤0.01%
+40
New +$1.18K

Similar funds

North Star Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, North Star Investment Management held 1,110 positions worth $1.06B, up 10% from $961M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

North Star Investment Management's Q1 2021 filing shows 65 new, 211 increased, 153 reduced and 37 closed positions. Its largest new stake was Phibro Animal Health: 55,925 shares worth $1.36M. The largest sale was Paramount Global Class B, an estimated $5.57M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, down from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

  • North Star Investment Management's largest Q1 2021 buy was Phibro Animal Health: 55,925 shares worth $1.36M.
  • North Star Investment Management added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q1 2021, an estimated $7.6M increase.
  • North Star Investment Management's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $5.57M.
  • North Star Investment Management fully exited Collectors Universe in Q1 2021, selling an estimated $2.79M.
  • North Star Investment Management's ten largest holdings make up 22% of its $1.06B portfolio in Q1 2021.
  • North Star Investment Management opened 65 new positions and closed 37 in Q1 2021.
  • North Star Investment Management's portfolio value rose 10% quarter-over-quarter to $1.06B.

Based on North Star Investment Management's 13F filing for Q1 2021, filed 19 Apr 2021.